“Plastic antibody” developer strengthens board following further investment from Mercia Fund Management
MIP Diagnostics Ltd, a Midlands-based life sciences start-up that develops “plastic antibodies” for a variety of applications has received £300,000 of follow-on funding from Mercia Fund Management for working capital growth. Mercia first invested in MIP Diagnostics, a spin-out from the University of Leicester, in March 2015 and since then it has continued to grow